🎉 M&A multiples are live!
Check it out!

Abbott India Valuation Multiples

Discover revenue and EBITDA valuation multiples for Abbott India and other public comps.

See Abbott India Valuation Multiples

Abbott India Overview

About Abbott India

Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.


Founded

1944

HQ

India
Employees

3.8K+

Website

abbott.co.in

Financials

LTM Revenue $734M

LTM EBITDA $189M

EV

$6.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Abbott India Financials

Abbott India has a last 12-month revenue of $734M and a last 12-month EBITDA of $189M.

In the most recent fiscal year, Abbott India achieved revenue of $675M and an EBITDA of $196M.

Abbott India expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Abbott India valuation multiples based on analyst estimates

Abbott India P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $567M $617M $675M $734M XXX
Gross Profit $259M $273M $302M XXX XXX
Gross Margin 46% 44% 45% XXX XXX
EBITDA $134M $157M $196M $189M XXX
EBITDA Margin 24% 25% 29% 26% XXX
Net Profit $92.2M $110M $139M XXX XXX
Net Margin 16% 18% 21% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Abbott India Stock Performance

As of February 14, 2025, Abbott India's stock price is INR 27859 (or $322).

Abbott India has current market cap of INR 592B (or $6.8B), and EV of INR 574B (or $6.6B).

See Abbott India trading valuation data

Abbott India Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$6.6B $6.8B XXX XXX XXX XXX $7.24

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Abbott India Valuation Multiples

As of February 14, 2025, Abbott India has market cap of $6.8B and EV of $6.6B.

Abbott India's trades at 9.0x LTM EV/Revenue multiple, and 35.1x LTM EBITDA.

Analysts estimate Abbott India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Abbott India and 10K+ public comps

Abbott India Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $6.6B XXX XXX XXX
EV/Revenue 9.1x XXX XXX XXX
EV/EBITDA 34.4x XXX XXX XXX
P/E 45.0x XXX XXX XXX
P/E/Growth 3.5x XXX XXX XXX
EV/FCF 53.1x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Abbott India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Abbott India Valuation Multiples

Abbott India's NTM/LTM revenue growth is 11%

Abbott India's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $37K for the same period.

Over next 12 months, Abbott India's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Abbott India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Abbott India and other 10K+ public comps

Abbott India Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 9% XXX XXX XXX XXX
EBITDA Margin 27% XXX XXX XXX XXX
EBITDA Growth 25% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 37% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $37K XXX XXX XXX XXX
S&M Expenses to Revenue 4% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 21% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Abbott India Public Comps

See valuation multiples for Abbott India public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Abbott India M&A and Investment Activity

Abbott India acquired  XXX companies to date.

Last acquisition by Abbott India was  XXXXXXXX, XXXXX XXXXX XXXXXX . Abbott India acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Abbott India

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Abbott India

When was Abbott India founded? Abbott India was founded in 1944.
Where is Abbott India headquartered? Abbott India is headquartered in India.
How many employees does Abbott India have? As of today, Abbott India has 3.8K+ employees.
Is Abbott India publicy listed? Yes, Abbott India is a public company listed on BOM.
What is the stock symbol of Abbott India? Abbott India trades under 500488 ticker.
When did Abbott India go public? Abbott India went public in 1992.
Who are competitors of Abbott India? Similar companies to Abbott India include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Abbott India? Abbott India's current market cap is $6.8B
What is the current revenue of Abbott India? Abbott India's last 12-month revenue is $734M.
What is the current EBITDA of Abbott India? Abbott India's last 12-month EBITDA is $189M.
What is the current EV/Revenue multiple of Abbott India? Current revenue multiple of Abbott India is 9.0x.
What is the current EV/EBITDA multiple of Abbott India? Current EBITDA multiple of Abbott India is 35.1x.
What is the current revenue growth of Abbott India? Abbott India revenue growth between 2023 and 2024 was 9%.
Is Abbott India profitable? Yes, Abbott India is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.